# Evaluation of PK and Safety of D-0120 and Allopurinol

> **NCT05360628** · EARLY_PHASE1 · COMPLETED · sponsor: **InventisBio Co., Ltd** · enrollment: 20 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** D-0120 in combination with Allopurinol

## Key facts

- **NCT ID:** NCT05360628
- **Lead sponsor:** InventisBio Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-01
- **Primary completion:** 2022-02-10
- **Final completion:** 2022-07-23
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2023-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05360628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05360628, "Evaluation of PK and Safety of D-0120 and Allopurinol". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05360628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*